who owns the patent for semaglutide Within weeks of expiry, multiple Indian pharma companies launched their own versions. As a result, prices now range from ₹1290 to ₹4,500+ depending on the format. This is how Semaglutide & Tirzepatide Patent Considerations

In a Phase 1 randomized, double-blind, placebo-controlled trial involving obese adults (NCT04478708), AMG 133 exhibited good safety and tolerability profiles and demonstrated significant dose-dependent weight loss effects

Int J Mol Sci 23:10087 Huihui Z, Xin L, Zisong X, Yue W, Zhiyuan T, Meijun A, Yuehui Z, Wenxu Z, Nan X, Guangyu S (2020) Toxic effects of heavy metals Pb and Cd on mulberry ( Morus alba L.) seedling leaves: photosynthetic function and reactive oxygen species (ROS) metabolism responses

What are the benefits of Semaglutide

You can reach our team of experts by calling us or messaging us on our contact form

Patients are scrambling between pharmacies